Simon Hawke
Simon Hawke
Honorary Professor, University of Sydney
Verified email at
Cited by
Cited by
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
AR White, P Enever, M Tayebi, R Mushens, J Linehan, S Brandner, ...
Nature 422 (6927), 80-83, 2003
Exosomal microRNA signatures in multiple sclerosis reflect disease status
S Ebrahimkhani, F Vafaee, PE Young, SSJ Hur, S Hawke, E Devenney, ...
Scientific reports 7 (1), 14293, 2017
Vasculitic neuropathy: a clinical and pathological study
SHB Hawke, L Davies, R Pamphlett, YP Guo, JD Pollard, JG McLeod
Brain 114 (5), 2175-2190, 1991
The pseudotumor syndrome: disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly
I Johnston, S Hawke, M Halmagyi, C Teo
Archives of neurology 48 (7), 740-747, 1991
Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.
S Riemersma, A Vincent, D Beeson, C Newland, S Hawke, ...
The Journal of clinical investigation 98 (10), 2358-2363, 1996
Regional heterogeneity of cellular prion protein isoforms in the mouse brain
V Beringue, G Mallinson, M Kaisar, M Tayebi, Z Sattar, G Jackson, ...
Brain 126 (9), 2065-2073, 2003
The immunogenicity of intracerebral virus infection depends on anatomical site
PG Stevenson, S Hawke, DJ Sloan, CR Bangham
Journal of virology 71 (1), 145-151, 1997
Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system
S Hawke, PG Stevenson, S Freeman, CRM Bangham
The Journal of experimental medicine 187 (10), 1575-1582, 1998
Incidence and prevalence of NMOSD in Australia and New Zealand
W Bukhari, KM Prain, P Waters, M Woodhall, MOG Cullen, L Clarke, ...
Journal of Neurology, Neurosurgery & Psychiatry 88 (8), 632-638, 2017
PrP glycoforms are associated in a strain-specific ratio in native PrPSc
A Khalili-Shirazi, L Summers, J Linehan, G Mallinson, D Anstee, S Hawke, ...
Journal of General Virology 86 (9), 2635-2644, 2005
PrPSc binding antibodies are potent inhibitors of prion replication in cell lines
V Beringue, D Vilette, G Mallinson, F Archer, M Kaisar, M Tayebi, ...
Journal of Biological Chemistry 279 (38), 39671-39676, 2004
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
F Tea, JA Lopez, S Ramanathan, V Merheb, FXZ Lee, A Zou, D Pilli, ...
Acta Neuropathologica Communications 7, 1-22, 2019
IgG monoclonal paraproteinaemia and peripheral neuropathy.
AF Bleasel, SH Hawke, JD Pollard, JG McLeod
Journal of Neurology, Neurosurgery & Psychiatry 56 (1), 52-57, 1993
Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
H Matsuo, AP Batocchi, S Hawke, M Nicolle, L Jacobson, A Vincent, ...
Journal of immunology (Baltimore, Md.: 1950) 155 (7), 3683-3692, 1995
Differential toxicity of antibodies to the prion protein
RR Reimann, T Sonati, S Hornemann, US Herrmann, M Arand, S Hawke, ...
PLoS pathogens 12 (1), e1005401, 2016
Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions: a double-blind study
JH Antony, SHB Hawke
American Journal of Diseases of Children 137 (9), 892-895, 1983
Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting
S Hawke, H Matsuo, M Nicolle, G Malcherek, A Melms, N Willcox
Immunology today 17 (7), 307-311, 1996
Protein conformation significantly influences immune responses to prion protein
A Khalili-Shirazi, S Quaratino, M Londei, L Summers, M Tayebi, ...
The Journal of Immunology 174 (6), 3256-3263, 2005
Effect of social drinking on neuropsychological performance
M WAUGH, M Jackson, GA Fox, SH Hawke, RR Tuck
British Journal of Addiction 84 (6), 659-667, 1989
Immunotherapy as a therapeutic treatment for neurodegenerative disorders
AR White, SH Hawke
Journal of neurochemistry 87 (4), 801-808, 2003
The system can't perform the operation now. Try again later.
Articles 1–20